Navigation Links
Syngenta and Metabolon Inc. in Collaborative Research Agreement for Biochemical Profiling Technology
Date:9/30/2008

WASHINGTON, Sept. 30 /PRNewswire-FirstCall/ -- Syngenta announced a multi-year agreement with Metabolon for biochemical profiling technology that will enhance the Syngenta technical toolkit for its seeds research programs. This agreement will support Syngenta researchers' understanding of plants' response to environmental conditions and decisions on crop traits earlier in the development cycle.

"Biochemical profiling is becoming an important part of Syngenta's focused program to apply the full range of cutting-edge science to supply solutions for growers," said Roger Kemble, Ph.D., Head, Syngenta Crop Genetics Research. "Metabolon's technology will enable Syngenta's insights to the performance of our products as we focus in bringing the next generations of seed science across native traits and GM paths to unlock crop productivity."

"We are excited to expand our partnership with Syngenta, a leading seed biotechnology company," said John Ryals, Ph.D., president and chief executive of Metabolon. "This agreement brings Syngenta into our growing stable of commercial partners in the pharmaceutical, biotechnology and consumer product sectors and we look forward to providing further actionable insight with our global biochemical analysis."

This agreement expands upon initial studies performed by Metabolon for Syngenta to test the application of the technology. Financial terms of the agreement were not disclosed.

Syngenta is a world-leading agribusiness committed to sustainable agriculture through innovative research and technology. The company is a leader in crop protection, and ranks third in the high-value commercial seeds market. Sales in 2007 were approximately $9.2 billion. Syngenta employs over 21,000 people in more than 90 countries. Syngenta is listed on the Swiss stock exchange (SYNN) and in New York (SYT). Further information is available at http://www.syngenta.com.

Cauti
'/>"/>

SOURCE Syngenta
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
2. Syngenta To Build Major Global Biotech Research Center in Beijing, China
3. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
4. Syngenta Licenses Chromatin Gene Stacking Technology
5. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
6. Palladian Muscular Skeletal Health (formerly Prism Health Networks) to Promote Collaborative, Expanded Practice Model at Major Insurance Conference in June
7. Collaborative Software Initiative Addresses State Governments Requirements for Meeting Infectious Disease Compliance
8. BIKAM and Dalton Medicinal Chemistry Sign Collaborative Research Agreement
9. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
10. Collaborative Biosecurity Research Initiative Launched to Target Animal and Public Health Threats Nationally
11. Biomoda Announces Collaborative Agreement With New Mexico Tech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Over the last decade, the laboratory filtration market ... and increased acceptance of new filtration technologies in end ... are also catalyzing the growth of laboratory filtration market. ... grow at a strong CAGR during the forecast period ... million by 2019. The market is mainly driven by ...
(Date:9/30/2014)... 2014 CORD:USE Cord Blood Bank – ... has entered into an Equity and Exclusive Services Agreement ... series of patented technologies for the isolation of human ... Tianhe is performing Phase I/II clinical trials in ... using Tianhe,s Stem Cell Educator Therapy showing that ...
(Date:9/30/2014)...  KemPharm, Inc., a clinical-stage specialty pharmaceutical company ... new molecular entity (NME) prodrugs, announced today that ... issued U.S. Patent No. 8,816,083 to KemPharm for ... Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydromorphone, ... The patent, which extends through 2032, provides ...
(Date:9/30/2014)... 30, 2014 The overall research objective ... sequencing trends and use. Most researchers outsource NGS ... to increase within the next 12 months. Data ... for purchasing sequencing instruments. Disease-related research is the ... RNA-Seq continues to surge, with half of the ...
Breaking Biology Technology:Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 2Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 3Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 4Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 5CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 2CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 3CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 4KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2Global Next-generation Sequencing Trends 2
... LAFAYETTE, Ind. - The National Nuclear Security Administration has ... center at Purdue University,s Discovery Park to develop advanced ... Friday (March 7). , The center will focus on ... one of five new Centers of Excellence chosen by ...
... LLY ) today announced the termination of development ... partnership with Alkermes,Inc. The program has been in phase ... and type 2 diabetes. The company noted that this,decision ... Insulin trials,relating to the safety of the product, but ...
... CHICAGO, March 7 Advanced Life Sciences,Holdings, Inc. ... has received notice,from the Nasdaq Listing Qualifications Department ... the bid price for the Company,s,common stock has ... for,continued inclusion under Marketplace Rule 4310(c)(4) (the "Rule"). ...
Cached Biology Technology:Purdue leads center to simulate behavior of micro-electromechanical systems 2Purdue leads center to simulate behavior of micro-electromechanical systems 3Purdue leads center to simulate behavior of micro-electromechanical systems 4Lilly Announces Termination of AIR Insulin Program 2Lilly Announces Termination of AIR Insulin Program 3Lilly Announces Termination of AIR Insulin Program 4Advanced Life Sciences Receives Nasdaq Notification 2Advanced Life Sciences Receives Nasdaq Notification 3
(Date:9/30/2014)... Calif. The National Institutes of Health (NIH) ... today to develop an electrode array system that ... brain works through unprecedented resolution and scale. , ... to support President Obama,s BRAIN (Brain Research ... research effort to revolutionize our understanding of the ...
(Date:9/30/2014)... scientists and engineers, led by Clemson University associate ... million grant from the U.S. Department of Energy,s ... a direct positive impact on South Carolina in ... radioactive contaminants. , "Understanding the scientific and engineering ... aspects of nuclear technologies is imperative if South ...
(Date:9/30/2014)... Journal of Medicine reports positive results of a ... the subset of lung cancer marked by rearrangement of ... patients with advanced non-small cell lung cancer testing positive ... percent, with 3 complete responses and 33 partial responses. ... the disease to resume its growth after being slowed ...
Breaking Biology News(10 mins):NIH taps lab to develop sophisticated electrode array system to monitor brain act 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 3Researchers get $5.25 million to advance nuclear technologies in South Carolina 2NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2
... species in the Amazon will survive even grim scenarios ... extinction rates of up to 50 percent, predict Smithsonian ... the journal Proceedings of the National Academy of ... be as they weather the next several decades of ...
... Medical Center and at the National Institute of Environmental ... chromosomes can recombine to change genomes and spawn new ... of repeated sequences in the genomes of most higher ... many repeats," said Lucas Argueso, Ph.D., a research scholar ...
... When you make a new material on a nano scale ... team lead by a Biotechnology and Biological Sciences research Council ... major challenge faced by nanotechnology scientists. With new research ... from the University of Liverpool, The School of Pharmacy (University ...
Cached Biology News:Extinction most likely for rare trees in the Amazon rainforest 2Duke-NIEHS team shows how DNA repairs may reshape the genome 2Scientists overcome nanotech hurdle 2Scientists overcome nanotech hurdle 3
HOXC11 Antibody...
Rabbit polyclonal to Raf1 ( Abpromise for all tested applications). entrezGeneID: 5894 SwissProtID: P04049...
Sheep polyclonal to hCG beta core fragment ( Abpromise for all tested applications). Antigen: Full length native protein (purified) from human urine. Entrez GeneID: 1082 Swiss Protein ID...
Mouse monoclonal [SIT-01] to SIT ( Abpromise for all tested applications). entrezGeneID: 27240 SwissProtID: Q9Y3P8...
Biology Products: